KARISSA EMERSON: Open Payments
NPI 1912490830 · FARGO, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 12 payments from 10 companies in 2025. Trend: 2023 $157 · 2024 $111 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $60 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Astellas Pharma US Inc | 1 | $25 |
| ABBVIE INC. | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Phadia US Inc. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| Actelion Pharmaceuticals US, Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
Products named: Intracept, NUCALA, Veozah, QULIPTA, General - Pain Management, Jornay PM, ImmunoCAP, Kerendia.
Industry payments across ND — which companies pay providers there.
